시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 장 중첩증 시장 보고서(2025년)
Intussusception Global Market Report 2025
상품코드 : 1825427
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

장 중첩증 시장 규모는 향후 수년간 안정된 성장이 전망됩니다. 2029년에는 CAGR 4.0%로 54억 6,000만 달러로 성장합니다. 예측 기간의 성장은 지속적인 의학 교육 구상, 소아 예방접종 프로그램, 소아 건강관리의 세계 구상, 수술 후 관리에 대한 집중, 소아 소화기 조사 수요 증가, 원격의료, 원격의료 접근성 증가에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 영상 진단의 발전, 저침습적 치료 접근법, 소아에 특화된 중재 개발, 병인 및 위험 요인 연구, 세계 역학 연구, 백신 접종 프로그램 시행, 진단 및 상담을 위한 원격의료 등이 있습니다.

향후 5년간 4.0%의 성장률 전망은 지난번 전망치보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 영국과 브라질에서 개발된 공기 관장기 축소 시스템 및 소아 수술 용품의 가격을 끌어올려 장 중첩증 치료 지연과 소아 응급실 비용 상승을 초래하여 소아 의료에 지장을 초래할 수 있습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

예상되는 장질환 유병률 증가는 향후 장 중첩증증 시장의 성장을 촉진할 것으로 보입니다. 장질환에는 소화기관에서 중요한 역할을 하는 장의 정상적인 기능에 영향을 미치는 다양한 질환이 포함됩니다. 염증성장질환 및 소화관암과 같은 장질환 증가는 조기 진단, 치료 옵션 개선, 장 중첩증 환자 지원 강화로 이어져 궁극적으로 건강 상태 개선에 기여합니다. 예를 들어 2023년 1월 미국암협회(ACS)의 데이터에 따르면 미국내 소화기암 발병 건수가 3.18% 증가하여 2021년 338,090건 대비 348,840건에 달할 것으로 예상했습니다. 따라서 장질환 유병률 증가는 장 중첩증증 시장의 성장을 가속할 것으로 예측됩니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Intussusception is a medical condition wherein one part of the intestine slides into an adjacent section, causing a blockage in the flow of food, fluids, and gas through the affected portion. This condition manifests with symptoms such as severe abdominal pain, vomiting, and bloody stools. Diagnosis of intussusception typically relies on symptoms, physical examination, and imaging tests.

There are two main types of intussusception are idiopathic intussusception and secondary intussusception. Idiopathic intussusception involves the telescoping or invagination of one part of the intestine into another, resulting in a blockage or obstruction that can often be treated non-surgically through procedures such as pneumatic or hydrostatic reduction. Treatment methods include enema reduction, surgery, and others, with diagnostic approaches such as barium enema, ultrasound, and X-ray. These services are generally provided by hospitals, clinics, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The intussusception market research report is one of a series of new reports from The Business Research Company that provides intussusception market statistics, including intussusception industry global market size, regional shares, competitors with an intussusception market share, detailed intussusception market segments, market trends and opportunities, and any further data you may need to thrive in the intussusception industry. This intussusception market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intussusception market size has grown steadily in recent years. It will grow from $4.45 billion in 2024 to $4.67 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to improved diagnostic capabilities, increased awareness and education, global healthcare infrastructure growth, research and development investments, collaboration among healthcare entities.

The intussusception market size is expected to see steady growth in the next few years. It will grow to $5.46 billion in 2029 at a compound annual growth rate (CAGR) of 4.0%. The growth in the forecast period can be attributed to continued medical education initiatives, pediatric vaccination programs, global efforts in pediatric healthcare, focus on postoperative care, rising demand for pediatric gastrointestinal research, telemedicine and remote healthcare access. Major trends in the forecast period include advancements in diagnostic imaging, minimally invasive treatment approaches, development of pediatric-specific interventions, research on etiology and risk factors, global epidemiological studies, implementation of vaccination programs, telemedicine for diagnosis and consultation.

The forecast of 4.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder pediatric care by inflating prices of air enema reduction systems and pediatric surgical supplies developed in the UK and Brazil, resulting in delayed treatment of bowel obstructions and higher pediatric emergency costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in the incidence of intestinal disorders is poised to drive the growth of the intussusception market in the future. Intestinal disorders encompass various medical conditions affecting the normal functioning of the intestines, which play a crucial role in the digestive system. The increasing occurrence of intestinal disorders, such as inflammatory bowel disease and gastrointestinal cancers, can lead to earlier diagnoses, improved treatment options, and enhanced support for patients with intussusception, ultimately contributing to better health outcomes. For instance, data from the American Cancer Society (ACS) in January 2023 revealed a 3.18% increase in gastrointestinal cancers in the United States, reaching 348,840 cases compared to 338,090 in 2021. Therefore, the rising incidence of intestinal disorders is expected to drive the growth of the intussusception market.

The growth of the intussusception market is being fueled by rising healthcare spending. This term encompasses the total financial resources allocated to the healthcare sector within a particular region, country, or organization. Increased healthcare spending is often driven by the need for medical interventions, diagnostic procedures, and potential surgical treatments associated with conditions like intussusception, which in turn affects overall healthcare expenditure. For example, in November 2023, the Canadian Institute for Health Information, a Canada-based organization, projected that total health spending in Canada would reach $344 billion in 2023, averaging $8,740 per person. This represents a 2.8% increase compared to the previous year, which experienced a mere 1.5% growth in health spending in 2022, indicating a significant recovery in healthcare investment. Thus, the rise in healthcare spending is contributing to the growth of the intussusception market.

Major companies in the intestinal pseudo-obstruction treatment market are actively involved in developing innovative drug therapies, such as NHE3 inhibitor treatment therapy, to provide reliable services to customers. NHE3 inhibitor treatment therapy involves the inhibition of the Sodium-Proton-Exchanger subtype 3 (NHE3) in the gut. For example, in April 2022, Ardelyx Inc., a US-based biopharmaceutical company, introduced IBSRELA, an NHE3 inhibitor treatment designed for irritable bowel syndrome with constipation (IBS-C) in adults. This therapy has the potential to improve gastrointestinal motility by inhibiting or blocking the activity of the Sodium-Hydrogen Exchanger 3 (NHE3) protein. The approval of IBSRELA was based on two Phase 3 trials involving over 1,200 IBS-C patients. The treatment significantly improved abdominal pain and bowel movements, meeting the primary endpoint. Notably, improvements were observed as early as Week 1 and sustained for 26 weeks in the long-term trial.

In March 2022, Pfizer Inc., a prominent US-based pharmaceutical manufacturing company, acquired Arena Pharmaceuticals, Inc. This acquisition is part of Pfizer's strategic efforts to bolster its portfolio of therapeutic candidates at various stages of development within the field of gastroenterology. Arena Pharmaceuticals, Inc., a US-based clinical-stage company, is actively involved in developing treatments for intestinal diseases, including intussusception (bowel obstruction). The acquisition aligns with Pfizer's commitment to advancing research and development in gastrointestinal therapeutics.

Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc., Steris PLC, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co. KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.

North America was the largest region in the intussusception market in 2024. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intussusception market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intussusception market consists of revenues earned by entities that provide diagnostic services such as clinical examination, magnetic resonance imaging, exploratory laparoscopy, or laparotomy that help in diagnosing and managing intussusception as a medical condition. The market value includes the value of related goods sold by the service provider or included within the service offering. The intussusception market also includes sales of drugs such as acetaminophen with codeine and ibuprofen. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intussusception Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intussusception market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for intussusception ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intussusception market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Intussusception Market Characteristics

3. Intussusception Market Trends And Strategies

4. Intussusception Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Intussusception Growth Analysis And Strategic Analysis Framework

6. Intussusception Market Segmentation

7. Intussusception Market Regional And Country Analysis

8. Asia-Pacific Intussusception Market

9. China Intussusception Market

10. India Intussusception Market

11. Japan Intussusception Market

12. Australia Intussusception Market

13. Indonesia Intussusception Market

14. South Korea Intussusception Market

15. Western Europe Intussusception Market

16. UK Intussusception Market

17. Germany Intussusception Market

18. France Intussusception Market

19. Italy Intussusception Market

20. Spain Intussusception Market

21. Eastern Europe Intussusception Market

22. Russia Intussusception Market

23. North America Intussusception Market

24. USA Intussusception Market

25. Canada Intussusception Market

26. South America Intussusception Market

27. Brazil Intussusception Market

28. Middle East Intussusception Market

29. Africa Intussusception Market

30. Intussusception Market Competitive Landscape And Company Profiles

31. Intussusception Market Other Major And Innovative Companies

32. Global Intussusception Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intussusception Market

34. Recent Developments In The Intussusception Market

35. Intussusception Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기